Survival analysis the outcome. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Bile Ducts, Intrahepatic Lymph Nodes Cells, Cultured

Organisms2

Strongylida Mice, Inbred C57BL

Diseases56

Breast Neoplasms Recurrence Disease Progression Neoplasm Recurrence, Local Lung Neoplasms Adenocarcinoma Lymphatic Metastasis Postoperative Complications Liver Neoplasms Brain Neoplasms Prosthesis Failure Colorectal Neoplasms Carcinoma, Squamous Cell Neoplasm Metastasis Carcinoma Neoplasms Kidney Failure, Chronic Neoplasm Invasiveness Ovarian Neoplasms Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Hepatocellular Stroke Glioblastoma Melanoma Esophageal Neoplasms Pancreatic Neoplasms Prostatic Neoplasms Chronic Disease Acute Disease Bone Neoplasms Rectal Neoplasms Kidney Neoplasms Myocardial Infarction HIV Infections Skin Neoplasms Cholangiocarcinoma Glioma Heart Failure Head and Neck Neoplasms Carcinoma, Renal Cell Nasopharyngeal Neoplasms Bile Duct Neoplasms Osteosarcoma Sarcoma Astrocytoma Cardiovascular Diseases Inhalant Abuse Multiple Myeloma Colonic Neoplasms Urinary Bladder Neoplasms Disease Models, Animal Lymphoma, Large B-Cell, Diffuse Carcinoma, Ductal, Breast Heart Arrest Endometrial Neoplasms

Chemicals and Drugs20

Tumor Markers, Biological Antineoplastic Agents Ki-67 Antigen Biological Markers Cyclophosphamide Cisplatin Fluorouracil Doxorubicin Receptor, erbB-2 Tumor Suppressor Protein p53 Neoplasm Proteins Receptors, Estrogen Prednisone Vincristine Immunosuppressive Agents Receptors, Progesterone Antibodies, Monoclonal RNA, Messenger Proto-Oncogene Proteins Antineoplastic Agents, Hormonal

Analytical, Diagnostic and Therapeutic Techniques and Equipment113

Survival Analysis Survival Rate Treatment Outcome Prognosis Kaplan-Meier Estimate Retrospective Studies Proportional Hazards Models Follow-Up Studies Disease-Free Survival Risk Factors Neoplasm Staging Prospective Studies Multivariate Analysis Cohort Studies Pregnancy Outcome Predictive Value of Tests Risk Assessment Immunohistochemistry Registries Combined Modality Therapy Incidence Antineoplastic Combined Chemotherapy Protocols Life Tables Severity of Illness Index Regression Analysis Longitudinal Studies Reoperation Chi-Square Distribution Chemotherapy, Adjuvant Prosthesis Failure Tissue Array Analysis Analysis of Variance Logistic Models Neoplasm Grading Randomized Controlled Trials as Topic Models, Statistical Probability Cause of Death Risk Treatment Failure Radiotherapy, Adjuvant SEER Program Reproducibility of Results Gene Expression Profiling Statistics, Nonparametric Biostatistics Kidney Transplantation Patient Selection Data Interpretation, Statistical Actuarial Analysis Case-Control Studies Odds Ratio Length of Stay Mortality Remission Induction Hospital Mortality Prosthesis Design Liver Transplantation Renal Dialysis ROC Curve Clinical Trials as Topic Drug Therapy, Combination Confidence Intervals Transplantation, Homologous Double-Blind Method Hip Prosthesis Sensitivity and Specificity Cementation Immunoenzyme Techniques Reverse Transcriptase Polymerase Chain Reaction Epidemiologic Methods Multicenter Studies as Topic Hospitalization Linear Models Tumor Burden Prevalence Research Design Oligonucleotide Array Sequence Analysis Neoadjuvant Therapy Endpoint Determination Glasgow Outcome Scale Drug Administration Schedule Arthroplasty, Replacement, Hip Hepatectomy Chemoradiotherapy Tomography, X-Ray Computed Life Expectancy Palliative Care Cross-Sectional Studies Models, Biological Breeding Knee Prosthesis Postoperative Period Mitotic Index Heart Transplantation Blotting, Western Propensity Score Magnetic Resonance Imaging Radiotherapy Disease Models, Animal Chemoembolization, Therapeutic Arthroplasty, Replacement, Knee Esophagectomy Pain Measurement Stents CD4 Lymphocyte Count Statistical Distributions Gastrectomy Limb Salvage Polymerase Chain Reaction Peritoneal Dialysis Biometry Activities of Daily Living

Psychiatry and Psychology4

Cannibalism Smoking Patient Compliance Inhalant Abuse

Phenomena and Processes27

Cell Survival Time Factors Graft Survival Pregnancy Outcome Pregnancy Chi-Square Distribution Gene Expression Regulation, Neoplastic Apoptosis Probability Risk Longevity Odds Ratio Recovery of Function Mutation Signal Transduction Graft Rejection Cell Proliferation Genotype Sensitivity and Specificity Dose-Response Relationship, Drug Algorithms Vascular Patency Breeding Phenotype Polymorphism, Single Nucleotide CD4 Lymphocyte Count Statistical Distributions

Disciplines and Occupations3

Outcome Assessment (Health Care)Immunohistochemistry Research Design

Anthropology, Education, Sociology and Social Phenomena7

Survival Quality of Life Socioeconomic Factors Age Distribution Sex Distribution Health Status Activities of Daily Living

Humanities1

Quality of Life

Information Science14

Survival Rate Registries Incidence Life Tables Cause of Death SEER Program Data Interpretation, Statistical Mortality Hospital Mortality Prevalence Glasgow Outcome Scale Databases, Factual Algorithms Life Expectancy

Named Groups4

Infant, Newborn Patient Dropouts Survivors African Americans

Health Care73

Survival Analysis Survival Rate Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Proportional Hazards Models Follow-Up Studies Disease-Free Survival Outcome Assessment (Health Care)Risk Factors Prospective Studies Multivariate Analysis Cohort Studies Predictive Value of Tests Age Factors Risk Assessment Registries Incidence Life Tables Severity of Illness Index Regression Analysis Longitudinal Studies Chi-Square Distribution Outcome and Process Assessment (Health Care)Sex Factors Analysis of Variance Logistic Models Randomized Controlled Trials as Topic Models, Statistical Probability Cause of Death Risk Treatment Failure Age of Onset SEER Program Reproducibility of Results Statistics, Nonparametric Patient Selection Data Interpretation, Statistical Actuarial Analysis Case-Control Studies Odds Ratio Length of Stay Mortality Hospital Mortality ROC Curve Clinical Trials as Topic Confidence Intervals Double-Blind Method Sensitivity and Specificity Epidemiologic Methods Multicenter Studies as Topic Hospitalization Linear Models Prevalence Socioeconomic Factors Bias (Epidemiology)Comorbidity Age Distribution Glasgow Outcome Scale Patient Compliance Cost-Benefit Analysis Life Expectancy Palliative Care Cross-Sectional Studies Postoperative Period Propensity Score Patient Outcome Assessment Sex Distribution Statistical Distributions Health Status Biometry Activities of Daily Living

Geographicals17

United States Europe France Italy Netherlands Spain Sweden Australia Great Britain Japan England Denmark China Macau California Germany Taiwan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Analysis Survival Rate Treatment Outcome Cell Survival Prognosis Kaplan-Meier Estimate Retrospective Studies Proportional Hazards Models Follow-Up Studies Disease-Free Survival Time Factors Outcome Assessment (Health Care)Survival Risk Factors Neoplasm Staging Prospective Studies Multivariate Analysis Cohort Studies Graft Survival Tumor Markers, Biological Pregnancy Outcome Predictive Value of Tests Age Factors Breast Neoplasms Risk Assessment Recurrence Immunohistochemistry Registries Disease Progression Combined Modality Therapy Neoplasm Recurrence, Local Incidence Antineoplastic Combined Chemotherapy Protocols Life Tables Lung Neoplasms Adenocarcinoma United States Severity of Illness Index Regression Analysis Lymphatic Metastasis Postoperative Complications Longitudinal Studies Reoperation Infant, Newborn Pregnancy Chi-Square Distribution Outcome and Process Assessment (Health Care)Chemotherapy, Adjuvant Liver Neoplasms Brain Neoplasms Prosthesis Failure Sex Factors Tissue Array Analysis Colorectal Neoplasms Carcinoma, Squamous Cell Analysis of Variance Logistic Models Neoplasm Metastasis Neoplasm Grading Carcinoma Gene Expression Regulation, Neoplastic Randomized Controlled Trials as Topic Antineoplastic Agents Models, Statistical Neoplasms Apoptosis Probability Kidney Failure, Chronic Cause of Death Neoplasm Invasiveness Ovarian Neoplasms Stomach Neoplasms Risk Carcinoma, Non-Small-Cell Lung Quality of Life Treatment Failure Cell Line, Tumor Age of Onset Radiotherapy, Adjuvant SEER Program Reproducibility of Results Gene Expression Profiling Statistics, Nonparametric Carcinoma, Hepatocellular Biostatistics Kidney Transplantation Ki-67 Antigen Patient Selection Longevity Stroke Biological Markers Glioblastoma Data Interpretation, Statistical Actuarial Analysis Case-Control Studies Odds Ratio Length of Stay Melanoma Mortality Recovery of Function

No FAQ available that match "survival analysis the outcome"